Comments

BioNTech Stock Price, Quotes and Forecasts

Q: What sector and industry does BioNTech (BNTX) operate in?

BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BNTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$95.81

At close: Jun 2 EDT

$107.59

11.7812.30%

Pre-Market: 8:46 AM EDT

BioNTech (BNTX) Forecast

News Earnings BioNTech (BNTX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

BioNTech Stock Price, Quotes and Forecasts | NASDAQ:BNTX | Benzinga

Explore BioNTech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BNTX.

Open	-
Close	-
Volume / Avg.	268.31K / 1.11M
Day Range	- - -
52 Wk Range	76.53 - 131.49
Market Cap	$25.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.83%
Days to Cover	5.78

Recent News

Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children

RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed.

Vandana Singh

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.

Tanya Rawat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	268.31K / 1.11M
Day Range	- - -
52 Wk Range	76.53 - 131.49
Market Cap	$25.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	5.83%
Days to Cover	5.78

About BioNTech SE

Sector

Health Care

Industry

Biotechnology

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, in...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioNTech (BNTX) stock?

You can purchase shares of BioNTech (NASDAQ:BNTX) through any online brokerage.

View our list of the best stock brokerages

Who are BioNTech (BNTX) competitors?

Other companies in BioNTech’s space includes: BeOne Medicines (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for BioNTech (BNTX) stock?

BioNTech has a consensus price target of $144.63.

What is the current price for BioNTech (BNTX)?

The stock price for BioNTech (NASDAQ: BNTX) is $107.59 last updated June 2, 2025 at 8:46 AM EDT.

Does BioNTech (BNTX) pay a dividend?

There are no upcoming dividends for BioNTech.

When is BioNTech (NASDAQ:BNTX) reporting earnings?

BioNTech’s Q2 earnings are confirmed for Monday, August 4, 2025.

Is BioNTech (BNTX) going to split?

There is no upcoming split for BioNTech.

What sector and industry does BioNTech (BNTX) operate in?

BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.